Overdose Prevention and Intervention Task Force August 9, 2017

Similar documents
The State of Substance Misuse and Addiction: Secondary Prevention Strategies. June 1, :00 pm 3:00 pm ET Audio: ;

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Governor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018

Overdose Prevention and Intervention Task Force January 10, 2018

Governor Raimondo s Task Force on Overdose Prevention and Intervention June 13, 2018

State Opioid Response (SOR) Grant

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Clackamas County Overdose Prevention and Recovery Support Projects. Apryl L. Herron, MPH Clackamas County Public Health Division

RI Centers of Excellence for the

Rural Prevention and Treatment of Substance Abuse Toolkit

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Aetna s Initiative on the Opioid Epidemic

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Hospitals Role in Addressing the Opioid Crisis

Potential Solutions to Epidemic Substance Abuse in US and Europe

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

OPIOID WORKGROUP LEADERSHIP TEAM

Maryland Medicaid and Opioid Epidemic

Changing Course: statewide efforts to combat the opioid epidemic in California

The Opioid Epidemic: The State of the State

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Rhode Island Community Overdose Engagement Summit. Guide to Developing A Municipal Overdose Response Plan

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Governor Raimondo s Task Force on Overdose Prevention and Intervention January 9, 2019

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

Fighting Today s Opioid Epidemic

Opioid Treatment Program Reimbursement Re-bundling Proposal

Opioid Task Force Kick-Off Meeting. February 29, 2016

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

Addressing the Opioid Epidemic in Tennessee

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

Hospitals Role in Addressing the Opioid Crisis

Oregon Opioid Overdose Prevention Initiative

Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

PHMC Integrated Health Services Overview

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

Maryland Association of Healthcare Executives presents:

Progress Report Maine Opiate Collaborative Recommendations. on the. October 2018

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School

Strategic Plan

Project Connections Buprenorphine Program

Subject: New Jersey A Na+onal Leader In The Fight Against The Opioid Epidemic Tuesday, September 19, 2017 at 12:05:35 PM Eastern Daylight Time

Opioid Best Practices

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Overdose Survivors Outreach Program (OSOP)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Overdose Prevention and Intervention Task Force February 14, 2018

Leveraging Arizona s Medicaid Program to Drive Delivery System Innovation

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

NYS Responses to Opioid Use

Addressing the Opioid Epidemic through a Public Health Lens

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

INCREASING ACCESS TO NALOXONE

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

What is the strategy?

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

Medicaid s Role in Combating the Opioid Crisis

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The UMass Medical School Opioid Conscious Curriculum

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Combating the Opiate Crisis in Ohio

A Community Response to a Community Crisis

The Opioid Epidemic: Overdose Data in NYC

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Office Based Addiction Treatment (OBAT) at Lowell Community Health Center. Shaun Farraher, MD Melanie Priestly, Director May 2018

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Combating Opiate Addiction

TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

Patient and Family Agreement on Opioids

Successful Prevention Strategies to Address the Opioid Crises

Session IV Future Directions for Treatment for Opioid User Disorder:

ADDRESSING THE OPIOID CRISIS:

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Public Health Impacts of 2016 West Virginia Legislation

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative

Preparing for New Hampshire Behavioral Health Summit December 3, 2015

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry

Enhanced Substance Abuse Management in Higher Risk Populations

Closing the Loop in Treating Opioid Addiction:

The Care Alliance for Opioid Dependence

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

The Opioid Addiction Crisis in the Northern Shenandoah Valley. A Community Response

Transcription:

Overdose Prevention and Intervention Task Force August 9, 2017 CO-CHAIRS: DIRECTOR NICOLE ALEXANDER-SCOTT, MD, MPH, RHODE ISLAND DEPARTMENT OF HEALTH DIRECTOR REBECCA BOSS, MA, RHODE ISLAND DEPARTMENT OF BEHAVIORAL HEALTHCARE, DEVELOPMENTAL DISABILITIES, AND HOSPITALS

48-hour Overdose Reporting System Data, 2 nd Quarter 2017 Meghan McCormick, MPH Drug Overdose Prevention Epidemiologist Rhode Island Department of Health August 9, 2017

Overview Under regulation R23-1-OPIOID, the Rhode Island Department of Health requires every health professional and hospital in Rhode Island to report all opioid overdoses or suspected overdoses within 48 hours. Online Data collection began October 2015 Previous paper reports back-entered Reporting completeness, accuracy, and timeliness varies by hospital

48-hour Overdose Reports by Week Quarter 1 2017 (January 1-March 31): 333 overdoses were reported. Quarter 2 2017 (April 1-June 30): 424 overdoses were reported. Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

Demographics: Gender 80% 70% Overdose by Gender, Quarters 1 and 2 2017 68% 60% 50% 40% 30% 32% 20% 10% 0% Female Male Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

Demographics: Overdose by Age 40% Overdoses by Age, Quarters 1 and 2 2017 38% 37% 35% 30% 25% 22% 20% 18% 18% 15% 10% 14% 15% 13% 11% 12% 5% 0% 24 and under 25-34 35-44 45-54 55+ Quarter 1 Quarter 2 Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

Naloxone at Discharge Quarter 1:. 234 of the 333 OD reports were discharged. Quarter 2: 262 of the 424 OD reports were discharged. Naloxone at Discharge, Quarters 1 and 2 2017 45% 42% 40% 38% 35% 34% 30% 25% 24% 20% 17% 17% 15% 10% 5% 6% 11% 4% 5% 0% Yes, naloxone was dispensed on-site at ED Not offered Patient refused The patient received a prescription for naloxone Unknown Quarter 1 Quarter 2 Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

On-site Counseling 50% 45% 40% 35% On-site Counseling of Discharged Patients, Quarters 1 and 2 2017 45% 45% 37% 37% 30% 25% 20% 15% 10% 8% 8% 10% 10% 5% 0% No, onsite counseling was not offered The patient refused Unknown Yes, patient received on-site counseling Quarter 1 Quarter 2 Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

48-hour Overdose Reporting Quarter 1: 43% of reports met the 48-hour requirement Quarter 2: 89% of reports met the 48-hour requirement Quarter 1: 71% of reports were made within 7 days Quarter 2: 99% of reports were made within 7 days

48-hour Overdose Reporting by Hospital Hospital Total Number of Reports Quarter 1 Percent of Reports within 48 Hours of Overdose Quarter 1 Total Number of Reports Quarter 2 Percent of Reports within 48 Hours of Overdose Quarter 2 Butler 0 - <5 100% Hasbro Less than 5 0% 0 - Kent 73 77% 107 87% Landmark 17 100% 36 100% Memorial 27 52% 37 62% Newport 11 0% 12 100% Our Lady of Fatima Rhode Island Hospital 15 100% 19 100% 127 7% 114 91% Roger Williams 17 100% 23 96% South County 7 57% 10 100% Miriam 17 5% 34 94% Westerly 19 47% 31 84% Women and Infants Less than 5 100% 0 - Data Source: 48-hour Overdose Reporting System, Rhode Island Department of Health

Health Equity Zone: Local Plan to Impact Rhode Island s Opioid Overdose Epidemic August 9, 2017

Presented by: Susan Jacobsen, MA, LMHC, CCM Director of Health Equity Initiatives Susanj@thundermisthealth.org Michael Adamowicz, MA, MSW, LICSW, QMHP Director, Medication Assisted Therapy MichaelA@thundermisthealth.org Christopher Durigan, PharmD Clinical Pharmacist ChristopherDu@thundermisthealth.org

Community Strategy Overdose Prevention and Recovery Local Implementation of Governor s Task Force on Overdose Prevention Action Plan Co-prescribe Naloxone Barriers: Highest risk patients do not fill Naloxone scripts Naloxone POC Prevention Rescue Police Pilot Naloxone initiative, behavioral health navigator Community Naloxone Strategy MOON Study Anchor Recovery Educate Community Recovery Treatment SBIRT MAT expansion PharmD pilot Develop Nurse-led model

Priority Area: Overdose Prevention & Recovery Overarching Goal: Save Lives Indicator Strategies /Supporting Activities Target Number of overdose deaths Health Equity Zone Collective Impact Data Source: RIDH Medical Examiner Reduce by 25% by 3/31/2019

Partnerships for Collective Impact: Shared Workplan, Goals, and Measurement Anchor/The Providence Center West Warwick Police Department Thundermist Health Center Kent Hospital Emergency Department Community Ambassadors Town of West Warwick PONI Probation and Parole

Rescue Goal: Naloxone as Standard of Care Lead Partners: West Warwick Police, The Providence Center Indicator Strategies/Supporting Activities Target Number of Naloxone kits distributed Number of ED visits for overdose First responder PD/EMS use of Naloxone (Number times/year) Training in Naloxone Rescue Data Source: PONI, ANCHOR, Thundermist Point of Care Naloxone Distribution Health Equity Zone Collective Impact Data Source: Kent Hospital; TPC Anchor ED (# home address WW) WWPD/TPC Diversion Partnership WWPD Naloxone Program EMS Data Source: WW Police Department 500 trained by 3/31/19 Minimum 30 kits distributed per 10,000 annually TBD TBD 100% of first responders trained

Rescue: Police Ride Along Behavioral Health Navigator Data Points: Ride Alongs Number of behavioral health navigator ride alongs Substance Use Disorder Percentage of individuals who received outreach for substance use disorder issues Events Number of clinician patrol or outreach events conducted with the officers Treatment Of individuals outreached, number who self-report connecting with treatment or recovery support services December 2016 February 2019 Training Location Outreach Encounters Self-Initiated Number of law enforcement officers trained Number of calls for SUD issues, percentage of more than once to same address/location Number of individuals who received outreach Types of encounters Number of encounters with self-initiated contact

Recovery Lead Partner: Anchor Recovery Center # Engaged # Diverted # of people connected to recovery # of coaches trained and employed Strategies /Supporting Activities Recovery Coach Academy at HEZ Recovery Leader/Advocate training Weekly All Recovery meeting and other volunteer led weekly groups (e.g., Alateen, Naranon, etc.) at West Warwick HEZ location Weekly wellness/physical activity sessions or special events designed and implemented by and/or for people in recovery Data Source: TPC/Anchor Target 200 individuals served by 3/31/19 12 Recovery Coaches Trained 6 placed in employment

Treatment Goal: Everyone Who Needs it Has Access Lead Partner: Thundermist Health Center Indicator Strategies /Supporting Activities Target Number of persons receiving MAT Thundermist Medication Assisted Treatment (MAT) Expansion Data Source: Thundermist Health Center Double patient capacity by 3/31/2019 Number of persons retained in MAT at 6 months Thundermist Medication Assisted Treatment (MAT) Expansion Data Source: Thundermist Health Center TBD

Funding instability and mid-year funding cuts place strategy at risk.

MEDICATION ASSISTED TREATMENT Access to Medication Assisted Treatment Access to Naloxone 21

There has been a marked increase of DATA 2000 Waivered Providers

However, the pace of overdoses still increases

Why? Impediments to Medication Assisted Treatment Need for more access to Naloxone

Impediments to Medication Assisted Treatment The choke point for taking on new MAT patients occurs at approximately 23% of total waiver. Causes: Scheduling three induction days in first week Average number of annual visits: General patients receive 4 visits MAT patients require 18 visits

Waiver Utilization Thundermist Location Number of Providers/ Waiver Amount Total MAT Panel Size Percent of Waiver Used Woonsocket 6/290 98 34% West Warwick 9/1070 186 17% Wakefield 2/130 62 48% Combined 18/1490 346 23%

Panel Size Significantly Decreases as Number of MAT Patients Increases MAT Panel of 0 MAT Panel of 30 MAT Panel of 100 Available Visits (1) 3168 (100%) 3168 (100%) 3168 (100%) MAT Patients 0 30 100 Number of Annual Visits For MAT Patients (2) 0 540 (17%) 1800 (56.8%) Balance 3168 (100%) 2628 (83%) 1368 (43%) Non-MAT Pts at 4 Visits Per Year (3) 792 (100%) 657 (83%) 342 (43%) Unique Patient Capacity 792 (100%) 687 (-13.3%) 442 (-44.2%)

Follow Through/Dropout at Outside Providers 60% of next day inductions referred to CODAC do not attend Patients cite difficulties with transportation, going to an unknown agency, a general loss of motivation and related issues

Lack of Near Real-Time Induction Resources for the Commercially Insured COEs accept only Medicaid products. Other opioid treatment programs are cash-only. The only option is for these patients to go on our wait lists.

So, what are our options?

Opportunities to Maximize Access 1. Sustainable funding 2. More waivered providers 3. Treatment programs that accept all insurances 4. Team-based and enhanced practice models Multi-disciplinary team (based on the Massachusetts Model) Recovery Peer Support Specialist

Sustainable Funding PM/PM or other population based payment Bundled payments that truly meet costs Additional codes for FQHCs and private providers Recovery specialists (Virginia, Minnesota, Tennessee) Nursing codes Modified Intensive Outpatient Program Others?

More Waivered Providers/More Waiver Use State loan repayment priority to providers willing to waiver and see 75% of waiver Modified HPSA scores in areas hard hit PCP/patient ratio must be dropped as 1 MAT patient = 4.7 non MAT patients Resources for team-based care to support PCPs

Treatment Programs that Accept all Insurances Require COEs to accept and insurances to pay for COEs, including commercial and Medicare plans as allowable by law.

Multi-Disciplinary MAT Team Allied staff will perform most tasks in the 3- day induction Add recovery support specialists

Increase Access to Naloxone Standing order Stigma PONI Limited supply and resources Co-prescribing Risk stratification High doses or chronic use of opioids High risk prescription medication combinations Illicit drug use

Increase Access to Naloxone But, prescription receiving

Increase Access to Naloxone Barriers to pharmacy model: Cost Uninsured patients Non-Medicaid plans and deductibles Needle phobia Prohibitive pharmacy policies Perception Both pharmacy and patient Lack of counseling/instructions on use Transportation Nature of addiction

Increase Access to Naloxone Point-of-Care Model Get Naloxone into patients hands Risk stratification Not likely to go to pharmacy Not able to afford copay/cost Extremely high risk Heroin use +/- Fentanyl Previous overdose Address/location Polysubstance abuse Family/friend of someone high risk

Increase Access to Naloxone Point-of-Care Model How can we do this? Funding for state supply - similar to vaccines Billing codes for distribution and counseling VNA model? Continued provider education

Questions?

Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals State Targeted Response Grant August 9, 2017 MICHELLE BROPHY, MS

Overview: State Targeted Response Grant The Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals (BHDDH) State Targeted Response (STR) Grant supplements existing opioid program activities and supports a comprehensive response to the opioid epidemic through integrated planning and monitoring. STR Grant funding is equivalent to $2,167,007/year for potentially two years with a maximum total of $4,334,014.

Overview: State Targeted Response Grant Funds five nurse care managers to five high-risk communities selected by the Screening, Brief Intervention, and Referral to Treatment (SBIRT) program. Provides psychiatry staff for the Rhode Island Centers of Excellence (COE) at Eleanor Slater Hospital (ESH) and enhances the Hospital s connection with the Opioid Treatment Health Home. Implements a Recovery Housing Pilot with 40 Level three beds for those at risk while transitioning from prisons to the community to prevent prison to addiction pipeline.

Overview: State Targeted Response Grant Provides Opioid Treatment Programs (OTP) Health Home (HH) with fentanyl testing kits for regular screenings Incentivizes providers to become DATA-waivered and adds a practicum to the ESH COE Enhances opioid education statewide and local communication strategies to the five at-risk communities Distributes naloxone kits to the Department of Corrections and to Rhode Island s Mobile Outreach and Education Program for distribution in targeted at-risk locations Supplements funding to the RIDOH Communications operations to boost awareness

Budget Breakdown: Year 1 of 2 Public Outreach Campaign 2.31% Recovery Housing Pilot 24.77% Fentanyl Testing Kits 2.77% Practicum - CME Training 3.46% Naloxone Kits 4.61% Administration, Supplies, and Travel 4.85% MAT Integration 23.07% Psychiatrists for ESH 23.07% High School Education Task Force 11.08%

Primary Outcomes: Year 1 Several key outcomes have been highlighted in the grant, including: Monthly number of accidental overdose deaths (Center for the Office of the State Medical Examiner) Monthly number of overdose deaths due to fentanyl (RIDOH) Monthly number of overdoses at Emergency Department (ED) admissions (RIDOH) Number of naloxone kits distributed per year (Rhode Island Naloxone Distribution program)

Primary Outcomes: Year 1 Cumulative number of persons receiving methadone treatment (BHDDH) Unique monthly contacts; number of persons who accept to meet with a peer recovery specialist in the ED (BHDDH) Total number of persons enrolled in substance use treatment programs per month (BHDDH)

PUBLIC COMMENT